Clinic
Dent Neurologic Group, LLP
Dent Neurologic Group, LLP was paid $4.12M by Medicaid between Jan 2018 and Dec 2024, across 40 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 34% of everything it billed.
33Billing provider infoDENT NEUROLOGIC GROUP, LLP
AMHERST, NY 14226
AMHERST, NY 14226
33aNPI1982754628assigned 01/12/2007
33bProvider typeMagnetic Resonance Imaging (MRI) Clinic/Center
28Total paid$4.12M
24GClaims55,811
24DCodes billed40
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Magnetic Resonance Imaging (MRI) Clinic/Center providers in New York
Rank by total paid#2 of 9
Median peer was paid$186K
This provider vs. median22×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 7,709 | $614K | |
| 2019 | 8,823 | $699K | |
| 2020 | 9,350 | $658K | |
| 2021 | 7,445 | $425K | |
| 2022 | 7,464 | $510K | |
| 2023 | 8,356 | $680K | |
| 2024incomplete | 6,664 | $536K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 34% | 19,247 | 19,003 | $1.39M |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 26% | 3,617 | 3,616 | $1.08M |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 5.7% | 2,063 | 2,062 | $234K |
| 95819 | 5.6% | 779 | 779 | $230K | |
| J0585 | Injection, onabotulinumtoxina, 1 unit | 5.1% | 271 | 189 | $209K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 3.9% | 1,546 | 1,420 | $160K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | 3.7% | 343 | 340 | $151K |
| 20553 | 2.9% | 3,362 | 3,277 | $118K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 2.7% | 2,172 | 1,696 | $113K |
| 99205 | Prolong outpt/office vis | 1.6% | 408 | 408 | $66K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 1.2% | 1,121 | 1,121 | $50K |
| 96375 | Therapeutic injection; each additional sequential IV push | 1.1% | 2,125 | 1,786 | $43K |
28 more codes
| 64405 | <1% | 652 | $39K | |
| 64450 | <1% | 639 | $39K | |
| 92540 | <1% | 475 | $37K | |
| 95886 | <1% | 577 | $36K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 3,992 | $31K |
| 96367 | <1% | 857 | $24K | |
| 64615 | <1% | 206 | $17K | |
| 76376 | <1% | 478 | $13K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 399 | $5K |
| 96415 | <1% | 139 | $4K | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 3,815 | $3K |
| 93041 | <1% | 869 | $3K | |
| 92546 | <1% | 41 | $3K | |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 1,421 | $2K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 41 | $2K |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 65 | $2K |
| A9578 | Injection, gadobenate dimeglumine (multihance multipack), per ml | <1% | 605 | $2K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,585 | $2K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,489 | $2K |
| 0012A | <1% | 38 | $2K | |
| 80305 | <1% | 207 | $1K | |
| 0011A | <1% | 32 | $1K | |
| 76377 | <1% | 13 | $621.84 | |
| 99442 | <1% | 12 | $448.92 | |
| 92537 | <1% | 13 | $357.84 | |
| 96127 | <1% | 40 | $245.91 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 45 | $37.24 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 12 | $14.23 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSABA, MARY BETH (BILLING OFFICE MANAGER)